New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

Lung cancer screening experts from around the globe delivered strategies and best practices for improving access to screening ...

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments.

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed ...

Researchers have unveiled a potential paradigm shift in treatment strategies that could significantly improve patients' ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

The HER2-specific tyrosine kinase inhibitor zongertinib was well tolerated and demonstrated promising efficacy in patients ...

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West ...